Mesazone 500 Tablet containing Mesalazine is used for the treatment of ulcerative colitis and inflammatory bowel disease (IBD). It helps in reducing inflammation in the intestinal lining and improving bowel health.
Mesalazine works locally in the gut to inhibit inflammatory mediators, thereby reducing symptoms such as abdominal pain, diarrhea, and rectal bleeding.
The tablet is widely prescribed in gastroenterology practice for long-term management of IBD, leading to consistent demand and repeat usage.
With increasing prevalence of chronic digestive disorders and growing awareness of gut health, this product offers strong business potential for retailers and distributors. Its long-term therapy requirement, steady prescription demand, and strong clinical acceptance make it a reliable product for consistent sales and growth in the gastroenterology segment.
Some patients may experience nausea, abdominal pain, headache, flatulence, or diarrhea. Rarely, kidney function changes, allergic reactions, or worsening of colitis symptoms may occur and require medical attention.
Mesazone 500 Tablet is indicated for the treatment and maintenance of remission in ulcerative colitis and other inflammatory bowel diseases. It helps reduce abdominal pain, diarrhea, rectal bleeding, and intestinal inflammation, improving gut health and disease control.
This medicine should be used under medical supervision. Regular monitoring of kidney function and blood parameters is recommended during long-term therapy. Do not discontinue abruptly without medical advice.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.